|Description||HCV is a blood-borne virus that causes liver disease. The effects of the infection vary from one individual to the next. Many people will remain symptom free, some will develop cirrhosis and a few will develop liver failure or primary liver cancer. of the population, 1 in 140 people in Scotland, are chronically infected Unlike hepatitis A and B, there is no vaccine against hepatitis C but infection is preventable through strategies that minimise transmission.Most people who become infected with hepatitis C are unaware of it at the time. Some people may briefly feel unwell, or may have nausea and vomiting and, rarely, jaundice.
Use for initial patient assessment, longer term disease progression and response to antiviral therapies|
|Indication||PCR should be used for diagnosis of active infection, long term disease progression and response to antiviral therapy|
|Collection Conditions|| Send samples to the laboratory without delay. Must be received within 24 hours from collection|
|Min. Vol||4ml (FULL tube)|
|Ref. Range (Male)|| |
|Ref. Range (Female)|| |
|Ref. Range (Paed)|| |
|Ref. Range Notes||
|Units|| - Not Defined -|
|IP Acute TAT||7 days|
|IP Routine TAT||7 days|
|GP Acute TAT||7 days|
|GP Routine TAT||7 days|
|Turnround Comment||Results may be available considerably earlier than stated turnaround time.|
Originally edited by : D Bennett. Review due on 01/12/2018 12:45:00. Published By K Roberts on 01/12/2017 12:45:00.